tiprankstipranks
Trending News
More News >
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
US Market

Marker Therapeutics (MRKR) Financial Statements

Compare
530 Followers

Marker Therapeutics Financial Overview

Marker Therapeutics's market cap is currently $19.12M. The company's EPS TTM is $; its P/E ratio is ―; Marker Therapeutics is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 6.59M$ 3.31M$ 9.01M$ 1.24M$ 466.79K
Gross Profit$ -6.88M$ -7.11M$ 5.32M$ -1.92M$ -18.41M
Operating Income$ -11.12M$ -14.58M$ -19.79M$ -39.48M$ -28.89M
EBITDA$ -4.53M$ -11.27M$ -19.79M$ -36.31M$ -27.63M
Net Income$ -10.73M$ -8.24M$ -29.93M$ -41.88M$ -28.71M
Balance Sheet
Cash & Short-Term Investments$ 19.19M$ 15.11M$ 11.78M$ 42.35M$ 21.35M
Total Assets$ 22.02M$ 17.13M$ 34.42M$ 68.14M$ 45.61M
Total Debt$ 0.00$ 0.00$ 7.62M$ 11.87M$ 12.26M
Net Debt$ -19.19M$ -15.11M$ -4.17M$ -30.48M$ -9.10M
Total Liabilities$ 3.46M$ 3.07M$ 14.82M$ 24.15M$ 18.27M
Stockholders' Equity$ 18.56T$ 14.05M$ 19.60M$ 43.99M$ 27.34M
Cash Flow
Free Cash Flow$ -10.91M$ -16.44M$ -31.92M$ -30.41M$ -29.29M
Operating Cash Flow$ -10.91M$ -16.44M$ -26.97M$ -27.28M$ -18.86M
Investing Cash Flow$ 0.00$ 18.66M$ -4.95M$ -3.13M$ -10.43M
Financing Cash Flow$ 14.99M$ 1.11M$ 202.13K$ 52.56M$ 6.74M
Currency in USD

Marker Therapeutics Earnings and Revenue History

Marker Therapeutics Debt to Assets

Marker Therapeutics Cash Flow

Marker Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis